Sodium-Glucose Cotransport Inhibition With Dapagliflozin in Type 2 Diabetes

OBJECTIVE: Dapagliflozin, a novel inhibitor of renal sodium-glucose cotransporter 2, allows an insulin-independent approach to improve type 2 diabetes hyperglycemia. In this multiple-dose study we evaluated the safety and efficacy of dapagliflozin in type 2 diabetic patients. RESEARCH DESIGN AND MET...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: List, James F., Woo, Vincent, Morales, Enrique, Tang, Weihua, Fiedorek, Fred T.
Format: Artigo
Sprog:Inglês
Udgivet: American Diabetes Association 2009
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2660449/
https://ncbi.nlm.nih.gov/pubmed/19114612
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc08-1863
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker